![]() |
市場調查報告書
商品編碼
2019233
藥品泡殼包裝市場機會、成長要素、產業趨勢分析及2026-2035年預測。Pharmaceutical Blister Packaging Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035 |
||||||
預計到 2025 年,全球藥品泡殼包裝市場價值將達到 233 億美元,年複合成長率為 7.7%,到 2035 年將達到 486 億美元。

市場成長主要受以下因素驅動:監管要求日益嚴格,強制要求使用防篡改和可追溯包裝;以及阻隔性材料在保護對水分和氧氣敏感的藥品方面的應用日益廣泛。已開發地區和新興地區的藥品產量不斷成長,這主要得益於慢性病患病率上升、人口老齡化以及醫療保健服務可及性的提高,從而進一步推動了市場需求。製藥公司擴大採用單劑量包裝,以提高患者用藥安全,同時遵守防偽法規,包括增強可追溯性和可靠的識別要求。這些趨勢正在加速整個製藥業對泡殼包裝解決方案的採用,從而提高產品保護、營運效率和供應鏈完整性。
| 市場範圍 | |
|---|---|
| 開始年份 | 2025 |
| 預測期 | 2026-2035 |
| 上市時的市場規模 | 233億美元 |
| 預測金額 | 486億美元 |
| 複合年成長率 | 7.7% |
預計到2025年,熱成型市場規模將達到118億美元,這主要得益於其能夠高效生產適用於片劑和膠囊的透明泡殼。熱成型技術具有可視性強、加工能力高以及與自動化包裝系統無縫整合等優點,因此在製藥生產設施中廣泛使用。
到2025年,藥品泡殼包裝市佔率將達到53.2%,反映出該領域對PVC和PET等塑膠的高度依賴。這些材料因其優異的成型性而備受青睞,能夠實現精確的腔體成型,從而容納片劑和膠囊。其卓越的透明度使內容物清晰可見,這對於品質控制和患者信任至關重要。此外,PVC和PET為大規模生產提供了經濟高效的解決方案,使製造商能夠在保持高產能的同時最大限度地降低材料成本。
預計到2025年,北美藥品泡殼包裝市佔率將達到34.7%。這一成長主要得益於大規模製藥製造地的普及、嚴格的監管標準以及醫院和零售藥局對單劑量包裝日益成長的需求。製藥公司和包裝供應商正投資於先進的自動化和永續的泡殼包裝解決方案,以提高營運效率、確保合規性並應對環境問題。
The Global Pharmaceutical Blister Packaging Market was valued at USD 23.3 billion in 2025 and is estimated to grow at a CAGR of 7.7% to reach USD 48.6 billion in 2035.

Market growth is fueled by stringent regulatory mandates requiring tamper-evident and traceable packaging, coupled with heightened adoption of high-barrier materials to protect moisture- and oxygen-sensitive drugs. Expanding pharmaceutical production in developed and emerging regions, driven by the rising incidence of chronic diseases, aging populations, and enhanced healthcare access, is further boosting demand. Pharmaceutical manufacturers are increasingly leveraging unit-dose packaging to enhance patient safety while complying with anti-counterfeiting regulations, including enhanced traceability and secure identification requirements. These trends are accelerating the adoption of blister packaging solutions that improve product protection, operational efficiency, and supply chain integrity across the pharmaceutical sector.
| Market Scope | |
|---|---|
| Start Year | 2025 |
| Forecast Year | 2026-2035 |
| Start Value | $23.3 Billion |
| Forecast Value | $48.6 Billion |
| CAGR | 7.7% |
The thermoforming segment reached USD 11.8 billion in 2025, due to its efficiency in producing transparent blister cavities suitable for tablets and capsules. Thermoforming technology ensures visibility, high throughput, and seamless integration with automated packaging systems, supporting widespread adoption across pharmaceutical production facilities.
The pharmaceutical blister packaging segment accounted for 53.2% share in 2025, reflecting the widespread reliance on plastics such as PVC and PET. These materials are highly favored due to their excellent formability, allowing precise cavity shaping to hold tablets and capsules. Their superior clarity ensures that the contents are clearly visible, which is important for both quality inspection and patient assurance. PVC and PET also offer cost-effective solutions for large-scale production, enabling manufacturers to maintain high throughput while minimizing material expenses.
North America Pharmaceutical Blister Packaging Market accounted for 34.7% share in 2025. The region's growth is supported by its large pharmaceutical manufacturing base, strict regulatory standards, and increasing demand for unit-dose packaging in hospitals and retail pharmacies. Pharmaceutical companies and packaging suppliers are investing in advanced automation and sustainable blister packaging solutions to enhance operational efficiency, maintain regulatory compliance, and address environmental concerns.
Key players operating in the Global Pharmaceutical Blister Packaging Market include ACG, Amcor plc, AptarGroup, Inc., Borealis AG, Carcano Antonio S.p.A., Caprihans India Limited, Constantia Flexibles, Dow, Honeywell International Inc., Huhtamaki, RENOLIT SE, Rohrer Corporation, Romaco Group, Sonoco Products Company, SUDPACK, Syensqo, Tekni-Plex, Inc., Tjoapack LLC, VinylPlus, WestRock Company, and Winpak Control Group. Companies in the Global Pharmaceutical Blister Packaging Market are strengthening their presence through strategic innovation and operational enhancements. They are investing in R&D to develop high-barrier, eco-friendly, and sustainable materials that meet evolving regulatory requirements and consumer expectations. Collaborations with pharmaceutical manufacturers and technology providers enable tailored packaging solutions and seamless integration into automated production lines. Expansion into emerging markets and regional manufacturing facilities ensures improved supply chain access and cost efficiency. Additionally, players focus on process automation, digital tracking, and serialization technologies to enhance product security, optimize operational throughput, and maintain competitive advantage in the global pharmaceutical packaging landscape.